Innerer Wert von S&P & Nasdaq Kontaktieren

Lite Strategy, Inc. LITS NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
50/100
1/4 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Lite Strategy, Inc. (LITS) — This stock currently has no analyst coverage. No price targets, ratings, or earnings estimates are available. This is common for preferred shares, warrants, OTC-traded securities, and smaller companies that are not followed by Wall Street analysts.

Analysten schätzen Gewinn pro Aktie (EPS) von $3.62 und Umsatz von $0.07B für das nächste Geschäftsjahr.

Gewinn pro Aktie (EPS) Erfolgsbilanz: 2024: tatsächlich $2.67 vs Schätzung $3.62 (verfehlt -26.2%). 2025: tatsächlich $-2.39 vs Schätzung $-6.28 (übertroffen +61.9%). Analysten-Genauigkeit: 1%.

GpA-Schätzungen — LITS

1%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024 Actual $2.67 vs Est $3.62 ▼ 35.6% off
2025 Actual –$2.39 vs Est –$6.28 ▲ 162.8% off
Profitability Outlook
Company has mixed profitability — some years profitable, some at a loss. Analysts expect the company to turn profitable.

Umsatzschätzungen — LITS

100%
Analyst Accuracy
Accurate
1 year compared
Actual vs Estimate
2024 Actual $0.065B vs Est $0.065B ▼ 0.0% off
Revenue Trend
Revenue has declined over the period shown. Analysts expect stable revenue going forward.
Kontaktieren
🎓
SharesGrow Akademie
Lernen Sie inneren Wert zu berechnen und unterbewertete Aktien zu finden.
Wöchentliche Live-Sessions
Nachricht senden